Friday 6 November 2026
Export MD’s income statement to Excel — free account
Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
- Revenue
- +1.72%
- EPS
- −27.6%
- Free cash flow
- −14.4%
- Total debt
- −4.11%
Quarter to September 2026, against a year earlier
31.73
1.07
−3.26%
Follow MD
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 8 | 7 |
+8 more TTM periods Free account |
| 17.25% | 20.39% | 20.89% | 20.28% | ||
| 6.92% | 8.26% | 8.57% | 7.52% | ||
ROIC |
13.27% | 12.69% | 11.97% | 13.55% | |
Return on Tangible Assets |
80.87% | 88.61% | 93.93% | 48.11% | |
Average Days of Receivables |
44.77 | 44.72 | 44.78 | 46.21 | |
Free Cash Flow per Share |
2.71 | 2.88 | 2.93 | 3.00 | |
Free Cash Flow |
209.59 | 228.61 | 237.32 | 252.63 | |
Capital Expenditures |
(17.29) | (18.25) | (21.39) | (18.46) | |
| Other line items | |||||
Cash ROIC |
11.31% | 12.23% | 13.20% | 12.87% | |
Accounts Receivable Turnover |
8.25 | 8.03 | 7.89 | 7.43 | |
Accounts Payable Turnover |
4.16 | 4.76 | 6.06 | 3.47 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
86.46 | 76.57 | 60.57 | 107.83 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.26) | (0.23) | (0.23) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.76% | 12.72% | 12.55% | 12.58% | |
Share Based Compensation of Revenue |
1.09% | 1.04% | 0.99% | 0.94% | |
Interest Coverage |
6.38 | 6.31 | 6.23 | 5.81 | |
Operating CF/Net income |
1.51 | 1.41 | 1.48 | 1.64 | |
Depreciation/Fixed assets |
0.65 | 0.61 | 0.57 | 0.58 | |
Capex/Depreciation |
(0.71) | (0.77) | (0.91) | (0.81) | |
Revenue per Share |
25.35 | 24.55 | 23.88 | 22.76 | |
Operating CF per Share |
2.94 | 3.11 | 3.20 | 3.22 | |
Capex per Share |
(0.22) | (0.23) | (0.26) | (0.22) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026